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ABSTRACT
The genetic programs that maintain hematopoiesis during steady state in physiologic conditions
are different from those activated during stress. Here, we show that hematopoietic stem cells
(HSCs) with deﬁciencies in components of the alternative NFjB pathway (the NFjB inducing
kinase, NIK, and the downstream molecule NFjB2) had a defect in response to stressors such
as supraphysiological doses of cytokines, chemotherapy, and hematopoietic transplantation.
NIK-deﬁcient mice had peripheral blood and bone marrow leukocyte numbers within normal
ranges (except for the already reported defects in B-cell maturation); however, HSCs showed
signiﬁcantly slower expansion capacity in in vitro cultures compared to wild-type HSCs. This was
due to a delayed cell cycle and increased apoptosis. In vivo experiments showed that NIK-
deﬁcient HSCs did not recover at the same pace as controls when challenged with myeloabla-
tive chemotherapy. Finally, NIK-deﬁcient HSCs showed a signiﬁcantly decreased competitive
repopulation capacity in vivo. Using HSCs from mice deﬁcient in one of two downstream targets
of NIK, that is, either NFjB2 or c-Rel, only NFjB2 deﬁciency recapitulated the defects detected
with NIK-deﬁcient HSCs. Our results underscore the role of NIK and the alternative NFjB path-
way for the recovery of normal levels of hematopoiesis after stress. STEM CELLS
2015;33:2825—2837
SIGNIFICANCE STATEMENT
The genetic programs that maintain hematopoiesis during steady state in physiologic conditions
are different from those activated during stress. NFkB is a family of transcription factors and
two main pathways have been described for NFkB activation. In this work, we show that NIK
(canonical pathway) deficient hematopoietic stem cells maintain normal level of hematopoiesis
under basal conditions but are functionally deficient under stress. In vivo repopulation capacity
and recovery from chemotherapy, and in vitro expansion were deeply affected by NIK
inactivation.
INTRODUCTION
Under homeostatic conditions, the continuous
production of billions of erythrocytes, leuko-
cytes, and platelets (PLT), and the maintenance
of the immune system rely in the self-renewal
and multipotential capacities of hematopoietic
stem cells (HSCs). A ﬁne regulation between
self-renewal and differentiation exists. Extrinsic
factors provided by the microenvironment
(adhesion molecules, cytokines, and chemo-
kines) [1, 2] as well as intrinsic factors such as
transcription factors members of the Hox fam-
ily [3], Bmi-1 [4], cell cycle regulators p21, p27
[5, 6], p18 [7], or the oxidative stress pathway
[8–10] have been reported to modulate HSC
activities during physiological conditions. HSCs
are also responsible for regenerating the
hematopoietic system after several pathologi-
cal and clinical situations that induce the acti-
vation of normally quiescent HSCs, and the
proliferation and differentiation that ensue
restores hematopoietic homeostasis [11, 12].
Less is known about the factors or mechanisms
that control the response of HSCs to stressors.
Deﬁciencies in molecular pathways involved in
the response of HSCs to stress could interfere
with the recovery after chemotherapy, hinder
the engraftment after HSC transplantation, and
also cause aplastic anemia.
NFjB is a family of transcription factors
composed of homo and heterodimers of
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proteins that include p105/50 (NFjB1), p100/p52 (NFjB2),
p65 (Rel-A), Rel-B, and c-Rel. NFjB stimulates the expression
of a panel of survival/antiapoptosis proteins and also modiﬁes
the expression of target genes of cell growth, proliferation,
differentiation, immune response, and inﬂammation [13–15].
These proteins are located in the cytoplasm in an inactive
state, but are released and translocated to the nucleus upon
activation. Two main pathways have been described for NFjB
activation. In the canonical pathway, IjB kinases (IKKa, IKKb,
and IKKc) phosphorylate IjB (particularly IjBa) molecules in
response to different activators (viruses, inﬂammatory cyto-
kines, mitogens, and T-cell receptor signaling). IjB is also
ubiquitinated and then degraded by the proteasome, releas-
ing the NFjB transcription factors. Members of the family of
TNF receptors (LTbR, CD40, BAFFR, and RANK) and some
viruses (Epstein-Barr virus and human immunodeﬁciency virus)
can activate NFjB through an alternative (noncanonical) path-
way. A central component of the noncanonical pathway is the
NFjB inducing kinase (NIK), a MAP kinase kinase kinase member
[16, 17]. NIK was described as a serine/threonine kinase that
interacted with TRAF2, activating NFjB [18]. NIK acts through
IKKa [19] and stimulates the phosphorylation, ubiquitination,
and processing of p100 [18, 20]. The processing of p100 gener-
ates p52 and induces nuclear translocation of RelB/p52 hetero-
dimers. NIK can also activate c-rel transactivation activity [21].
Many groups have studied the role of NIK and the nonca-
nonical pathway in the immune system. Inactivation or deﬁ-
cits in this pathway negatively affected the numbers and
functions of B and T lymphocytes [22, 23], and the structure
of lymphoid organs [24]. Deﬁciencies in NIK activity resulted
in impaired models of immune diseases such as graft versus
host disease (GVHD) [21, 25], experimental autoimmune
encephalomyelitis (EAE) [26], and arthritis [27]. Conversely,
deregulated (constitutively activated) activation of the nonca-
nonical NFjB pathway has been described in human diseases
and contributes to the development of lymphoid malignan-
cies [28–31], multiple myeloma [32], and solid tumors
[33–36]. However, there are few studies on the role of NIK or
the alternative pathway in HSCs function [37]. We previously
described that GVHD did not occur when donor cells had an
inactive NIK protein, due to increased apoptosis of T lympho-
cytes [21]. In this article, we have focused on the role of NIK
in another major item in stem cell transplantation, that is,
hematopoietic regeneration. We found that NIK deﬁciency
confers a proliferative disadvantage and increased apoptosis
in HSCs in the transplantation context, and conﬁrmed these
ﬁndings in different stressful conditions. All these defects
were recapitulated using HSCs from an NFjB2-deﬁcient
mouse. Our results underscore a role for NIK and the alterna-
tive NFjB pathway in HSCs function after stressful situations.
MATERIALS AND METHODS
Mice and Irradiation Procedures
NIK-deﬁcient aly/aly mice (NIKaly/aly) [22], NFkB22/2 [38],
and cRel2/2 mice [39], all in the C57BL6 background, have
been previously described. C57BL6 (WT, CD45.2), P3B
(CD45.1), and P3D2F1 (CD45.1/CD45.2) mice were used as
donors and recipients in experiments of bone marrow (BM)
transplant. Experimental procedures were performed at CIE-
MAT Laboratory Animals Facility (registration number 28079-
21 A) and Centro de Biologıa Molecular Severo Ochoa (regis-
tration number 28079-19A). Mice aged 8–12 weeks old were
used. P3B recipient mice (CD45.1 females) were irradiated
with two doses of 5.5 Gy spaced 24 hours. Animals were
irradiated with Philips MG 324 X-ray equipment (Philips, Ham-
burg, Germany, http://www.healthcare.philips.com). All experi-
mental procedures were carried out according to European
and Spanish laws and regulations (European convention ETS 1
2 3, about the use and protection of vertebrate mammals
used in experimentation and other scientiﬁc purposes; Span-
ish RD 1201/2005, about the protection and use of animals in
scientiﬁc research). The Animal Experimentation Ethical Com-
mittee of the CIEMAT approved procedures, according to all
external and internal biosafety and bioethics guidelines.
Flow Cytometry
Peripheral blood (PB) or BM cells were ﬁrst incubated with
monoclonal antibodies for 30 minutes at 48C, and then lysed
(QuickLysis, Cytognos, Salamanca (Spain), http://www.cytognos.
com/) for 20 minutes at room temperature to eliminate
erythrocytes. Flow cytometry acquisition and analysis were per-
formed on a FACS Canto II cytometer (BD Bioscience, Franklin
Lakes, NJ, http://www.bdbiosciences.com/eu/home) using the
FACS Diva software.
To analyze engraftment kinetics, PB or BM cells were stained
with CD45.2-FITC (BD Bioscience, Franklin Lakes, NJ, http://
www.bdbiosciences.com/eu/home) or CD45.2-APC (Immuno-
step, Salamanca, Spain. http://immunostep.com/) antibodies. To
analyze lineage differentiation, cells were stained with CD3-
PECy7 (BD Bioscience, Franklin Lakes, NJ, http://www.bdbio
sciences.com/eu/home), B220-PE (BD Bioscience, Franklin Lakes,
NJ, http://www.bdbiosciences.com/eu/home), and GR1-PE (Biol-
egend, San Diego, CA, http://www.biolegend.com). For pheno-
type analysis, hematopoietic cells were harvested from BM,
lysed, and stained with a cocktail of differentiation markers APC-
or FITC-conjugated (BD Bioscience, Franklin Lakes, NJ, http://
www.bdbiosciences.com/eu/home). Monoclonal antibodies
used for ﬂow cytometry analysis of immature progenitors were:
CD117/c-kit APCCy7 (Biolegend), Sca1 PE-Cy7 (BD Bioscience,
Franklin Lakes, NJ, http://www.bdbiosciences.com/eu/home),
CD48 PE-Cy7 (BD Bioscience, Franklin Lakes, NJ, http://www.
bdbiosciences.com/eu/home), CD244.2 PE (BD Bioscience,
Franklin Lakes, NJ, http://www.bdbiosciences.com/eu/home),
CD150 FITC (BD Bioscience, Franklin Lakes, NJ, http://www.
bdbiosciences.com/eu/home), CD34-FITC (BD Bioscience, Frank-
lin Lakes, NJ, http://www.bdbiosciences.com/eu/home), FLK2/
CD135-PE (BD Bioscience, Franklin Lakes, NJ, http://www.bdbio-
sciences.com/eu/home), Sca1-APC-Cy7 (Biolegend, San Diego,
CA, http://www.biolegend.com), CD150-APC (Biolegend, San
Diego, CA, http://www.biolegend.com), and CKit/CD117-PECy7
(Biolegend, San Diego, CA, http://www.biolegend.com).
For cell cycle analysis, BM or Lin2Sca11cKit1 (LSK) sorted
cells were stained in cold Hoechst staining buffer with 5 lg/
ml Hoechst 33342 at 378C, 45 minutes. Pyronin Y was added
at a ﬁnal concentration of 0.5lg/ml and the cells were fur-
ther incubated 45 minutes [6]. Then cells were spun down
(48C), stained for surface markers, and resuspended in ice-
cold Hoechst staining buffer.
For LSK sorting, we used a Beckman Coulter EPICS ALTRA
Cell Sorter (Beckman Coulter, Fullerton, CA. www.beckman
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coulter.com). Apoptotic/dead cells were identiﬁed by annexin-
V (PE or APC, BD)/7-amino-actinomycin D (or DAPI).
Competitive Repopulation Assay and Serial
Transplantation
For lineage negative (Lin2) puriﬁcation, BM cells were
obtained from the femurs and tibias of donor mice and
depleted of lineage-positive cells with the Lineage Cell Deple-
tion Kit (Miltenyi Biotech, Bergisch Gladbach, Germany,
http://www.miltenyibiotec.com/) following the manufacturer’s
recommendations. For competitive repopulation assay Lin2
cells (or total BM) from NIKaly/aly, NFkB22/2, or cRel2/2
(CD45.2) male mice were mixed at 1:1 or 1:3 ratios with com-
petitor P3B (CD45.1) cells. A total of 107 total BM cells or
23 105 Lin2 cells were transplanted into lethally irradiated
P3D2F1 or P3B female. Engraftment kinetics and lineage differ-
entiation markers in PB were analyzed monthly by ﬂow cytom-
etry. LSK phenotype of CD45.2 population was analyzed in BM
of transplanted mice at 5 months post-transplantation. At this
time, BM cells from primary recipients were obtained, and 107
chimeric total BM cells were transplanted into lethally irradi-
ated P3B female in serial transplant assays. Engraftment
kinetics was analyzed at PB 1 and 2 months after secondary
transplants. DNA was extracted from PB using DNAeasy Mini
Kit (Qiagen, Hilden, Germany. https://www.qiagen.com), and
exogenous reconstitution was determined by Q-PCR analyses,
conducted in a 7500 Real-Time PCR System (Life Technologies,
Applied Biosystem. Foster City, CA, www.lifetechnologies.com),
and using primers and a probe for the SRY gene, speciﬁc to
the Y chromosome as described before [40].
Homing Assay
A total of 53 106 BM cells from NIKaly/aly or WT were trans-
planted into lethally irradiated female P3B mice. After 16
hours, mice were sacriﬁced and CD45.2 engraftment was ana-
lyzed by ﬂow cytometry of BM.
BM Transplantation and 5-Fluorouracil Treatment
5-Fluorouracil (5-FU, Sigma Chemicals, St. Louis, MO, http://
www.sigmaaldrich.com/) was administered at a dose of
150mg/kg b.wt. through tail vein in mice transplanted with
NIKaly/aly, NFkB22/2, or WT BM cells, 2 months after BM
transplantation. PB cell counts (Beckman Coulter, Fullerton,
CA, www.beckmancoulter.com) and BM cellularity were deter-
mined at the indicated time points. Percentage of LSK cells,
apoptosis, and cell cycle status were analyzed from BM cells
at 2 and 6 days post-treatment.
Western Blot Analysis
Western blot analyses were performed using whole cell lysate
prepared from BM from 5-FU treated mice prepared with RIPA
buffer (Sigma Chemicals, St. Louis, MO, http://www.sigmaaldrich.
com/). Samples were separated on 10% polyacrylamide gels and
transferred to nitrocellulose membranes for antibody detection.
All membrane-blocking steps and antibody dilutions were per-
formed with 5% Bovine Serum Albumin (BSA) in Tris Buffered
Saline (TBS) containing 0.1% Tween 20 (TBS-T), and washing steps
performed with TBS-T. The primary antibodies used were anti
P100 (4882, Cell Signaling Technology, Danvers, Massachusetts,
http://www.cellsignal.com/) and anti-Actin (I-19) (SC16 16 Santa
Cruz Biotechnology, Inc.Dallas, TX, http://www.scbt.com). After
incubating with HRP-coupled secondary antibodies, Western
blots were visualized by Immun-Star WesternC (Bio-Rad Labora-
tories, S.A., Alcobendas, Spain, http://www.bio-rad.com/).
In Vitro Cultures
Clonogenic assays were done to determine granulocyte-
macrophage colony-forming units (CFU). Total BM cells were
seeded in MethoCult GF M3534 culture media (Stem Cell
Technologies, Vancouver, BC, Canada, http://www.stemcell.
com/) and cultured at 378C in 5% CO2 and fully humidiﬁed
air. Colonies were scored after 7 days of culture.
105 Lin2 puriﬁed cells or 104 freshly sorted LSK cells from
NIKaly/aly and WT mice BM were cultured in Iscove’s Modiﬁed
Dulbecco’s Medium (IMDM) (Gibco Laboratories, Grand Island,
NY, www.lifetechnologies.com) medium with 20% Fetal Bovine
Serum (FBS) (Lonza, Basel, Switzerland, http://www.lonza.com),
Glutamine/Pen-strepto (Gibco Laboratories, Grand Island, NY,
www.lifetechnologies.com), 100 ng/ml hIL11 (Miltenyi Biotech,
Bergisch Gladbach, Germany, http://www.miltenyibiotec.com/),
and 100ng/ml mSCF (Miltenyi Biotech, Bergisch Gladbach,
Germany, http://www.miltenyibiotec.com/) [41]. Total cells
were counted weekly, and diluted to the initial concentration.
For proliferation assay, Lin2 cells were stained with Carboxy-
ﬂuorescein succinimidyl ester (CFSE) (Molecular Probes. Eugene,
OR, www.lifetechnologies.com) following manufacturer’s instruc-
tions. Labeled cells were cultured in supplemented medium and
CFSE dilution was analyzed daily by ﬂow cytometry. Apoptosis
was also analyzed in these cultures as explained before.
Gene Expression Microarray
Total RNA was isolated from freshly sorted LSK population of
WT and NIKaly/aly mice using TRIzol reagent (Invitrogen, Carls-
bad, California, www.lifetechnologies.com) and its quality
checked in the Agilent 2100 Bioanalyzer platform (Agilent
Technologies, Santa Clara, CA, http://www.chem.agilent.com/).
To produce Cy3-labeled cRNA, the RNA samples were ampliﬁed
(using a linear T7-based ampliﬁcation step) and labeled using
the Agilent Low Input Quick-Amp Labeling kit (Agilent Technol-
ogies, Santa Clara, CA, http://www.chem.agilent.com/). The
hybridization procedure was performed according to the Agi-
lent 60-mer oligo microarray processing protocol using the Agi-
lent Gene Expression Kit to a Agilent Whole Mouse Genome
Oligo Microarrays 8x60K. We analyzed three samples as inde-
pendent triplicates for NIKaly/aly and for WT. Each LSK sample
was the pool of three to four mice. Microarray analysis was
performed with Agilent Whole Mouse Genome Oligo Microar-
rays. Student’s test was applied on the normalized log 2-ratio
intensity data to distinguish expression differences between
WT and NIKaly/aly sample groups. Candidate genes were
required to have an expression difference of at least 1.5-fold,
with p-value less than or equal to .05. Search for transcription
factor binding sites was performed with MatInspector
(Genomatix, M€unchen, Germany, www.genomatix.de). Pathway
analysis was carried out on the Ingenuity Pathway Analysis
(IPA) platform (Qiagen, Hilden, Germany, https://www.qiagen.
com). Microarray data are available under GSE63702 at http://
www.ncbi.nlm.nih.gov/geo/.
Statistics
All statistical analyses were performed using Stata/IC 11.0
(StataCorp LP, College Station, TX, http://www.stata.com/).
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The nonparametric Wilcoxon rank-sum test was used to com-
pare quantitative variables. Results were considered statisti-
cally signiﬁcant with p< .05. All graphics present the
mean6 SE.
RESULTS
Hematopoiesis of NIK-Deficient aly/aly Mice Is Normal
Under Steady-State Conditions
Basal hematopoiesis was studied in PB and BM of adult
NIKaly/aly and WT mice. Apart from the already reported
defects in B-cell maturation [22–24], NIKaly/aly mice did not
present major disturbances in PB leukocyte numbers. The cel-
lularity of white blood cells (WBC), PLT, and red blood cells
was not signiﬁcantly different comparing mutant and wild-
type mice. Cellularity and lineages in BM were also within
normal ranges (Supporting Information Fig. S1A).
To study the committed compartment, we next performed
clonogenic assays from BM cells. NIKaly/aly mice presented
numbers of CFU colonies that were not signiﬁcantly different
than those of controls (Fig. 1A).
To study the stem cell compartment, we analyzed BM
using multiparametric ﬂow cytometry. Several populations
containing hematopoietic stem and progenitor cells, such as
LSK [42, 43], LT-HSC (LSK CD135-CD1501CD342) [44], ST-HSC
(LSK CD1352CD1501CD341), MPP (LSKCD1351), or the
SLAM (LinnegCD1501CD482) HSCs [45, 46] were studied
(Fig. 1B and Supporting Information Fig. S1B). Although values
tended to be lower in LSK, LT-HSC, and SLAM populations
(not in ST-HSC and MPP), there were no statistically signiﬁcant
differences in any populations between NIKaly/aly mice and
those in WT. Proportions of Sca11 cells in NIKaly/aly BM were
lower than in WT, reﬂecting the deﬁcit in B-cell progenitors
[47]. In addition to the HSC phenotype, we found similar dis-
tribution of cells in the G0, G1, and S/G2/M phases of the cell
cycle in LSK and SLAM HSCs from NIKaly/aly BM compared
with control mice, in the steady state (Fig. 1C). All the above
indicated that NIK inactivation (aly mutation) did not affect
mature PB lineages (except for B-cells), progenitor compart-
ment, absolute numbers and quiescence of HSC subpopula-
tions in steady-state hematopoiesis.
NIK
aly/aly
Mice Show a Defect in Reconstitution Ability
We next studied the effects of NIK deﬁciency in situations of
stress. Since recovery of the hematopoietic system after BM
transplantation is the most stressful condition for HSCs, we
performed a serial transplantation assay using cells from
NIKaly/aly and WT BM cells. We ﬁrst transplanted CD45.2 cells
into lethally irradiated P3B mice (107 cells per recipient ani-
mal). NIKaly/aly and WT HSCs similarly and completely reconsti-
tuted the hematopoiesis of primary recipients in a WT
environment (Fig. 2A). Two months after this ﬁrst transplant,
CD45.2 donor-derived cells were recovered from BM (with
similar engraftment values than PB, data not shown), mixed
at a 3:1 ratio with fresh competitor CD45.1 cells, and trans-
planted into lethally irradiated mice (P3D2F1, CD45.1/CD45.2)
(Fig. 2A). Short- and long-term hematopoiesis were analyzed
monthly in PB. We found that NIKaly/aly PB chimerism was sig-
niﬁcantly lower than WT at 1 month post-transplant (mpt)
(Fig. 2A and Supporting Information Fig. S2A), and decreased
over time in secondary recipients (Fig. 2A and Supporting
Information Fig. S2A). These data indicate that NIK deﬁciency
promotes HSC depletion during serial transplantation.
To further evaluate the self-renewal capacity of NIKaly/aly
and WT HSC in vivo, we performed a competitive repopulat-
ing assay using linage-depleted BM cells (Lin2 population),
where Lin2 CD45.21 cells (NIKaly/aly or WT) were mixed at a
1:1 ratio with competitor Lin2 CD45.11 (P3B mice) and trans-
planted into lethally irradiated (CD45.1, P3B male) mice (Fig.
2B). Endogenous hematopoiesis analyzed was consistently
lower than 10% (data not shown) [40]. The level of engraft-
ment of NIKaly/aly-derived cells was analyzed monthly in PB.
Engraftment level at 1 mpt (short-term reconstitution ability)
of NIKaly/aly CD45.21 cells was comparable to that of WT
CD45.21 cells but this contribution decreased in the long-
term (Fig. 2B). The values of NIKaly/aly CD45.21 were signiﬁ-
cantly lower than the WT at 5 mpt, in PB (Fig. 2B) and BM
(Fig. 2C). Further analysis of BM in recipient mice showed
that NIK deﬁciency resulted in a signiﬁcant decrease of abso-
lute numbers of LSK 5 mpt (Fig. 2D), suggesting that NIKaly/aly
HSCs have diminished self-renewal ability.
We also analyzed lineage differentiation in PB of recipi-
ents, and found that both NIKaly/aly and WT HSCs repopulated
a multilineage hematopoiesis upon transplantation (Support-
ing Information Fig. S2B). A signiﬁcant difference was
observed in the contribution of myeloid versus B lymphocytes
compartment in the reconstitution of NIKaly/aly and WT hema-
topoiesis (Supporting Information Fig. S2B).
To further conﬁrm a defect in reconstitution ability, chi-
meric BM cells were retransplanted into secondary recipient
mice 5 mpt. The low engraftment values of CD45.2 NIKaly/aly
were maintained at minimal percentages (Fig. 2E). The analy-
ses of PB of secondary recipients conﬁrmed the repopulation
capacity defect of the HSCs with a NIK inactivated protein.
NIK
aly/aly
HSCs Show a Intact Homing Ability
To rule out whether the defect in reconstitution ability
showed by NIKaly/aly HSC was secondary to a defect in hom-
ing, we transplanted total BM from NIKaly/aly mice or WT into
lethally irradiated P3B mice and analyzed marrow and spleen
16 hours after transplant. The absolute numbers of donor LSK
CD45.21 cells were similar comparing NIKaly/aly versus WT
(Fig. 3). This data suggested that NIK activity is dispensable
for the efﬁcient homing of HSCs in the BM. Thus, our results
clearly indicated a defective repopulation ability of NIKaly/aly
HSCs, not due to a defect in their homing ability.
NIK
aly/aly
HSCs Show a Delayed Hematopoietic
Recovery After Myeloablative Chemotherapy
To further evaluate the inﬂuence of NIKaly/aly mutation on the
reconstitution capacity of HSCs under hematopoietic stress, we
analyzed HSC at different points following myeloablative chem-
otherapy. 5-FU is a known myeloablative agent used in cancer
therapy. In the hematopoietic system, 5-FU kills cycling cells,
including progenitors, and induces the cycling of more primitive
HSCs. To conﬁrm that 5-FU therapy activated the NFkB alterna-
tive pathway in hematopoiesis, we treated NIKaly/aly and WT
mice with 5-FU and did Western blot on extracts from BM cells.
A signiﬁcant reduction in the expression of p52 was found in
aly/aly mice, while p100 was detected at comparable levels
compared to control [24] (Supporting Information Fig. S3).
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To exclude the potential effects of 5-FU on nonhemato-
poietic tissues, we ﬁrst transplanted NIKaly/aly or WT BM cells
into lethally irradiated CD45.1 mice. Two months later, we
conﬁrmed total engraftment of donor cells [48]. A single dose
of 5-FU was injected and WBC counts were obtained at 4, 10,
15, and 32 days post-treatment (dpt). PB counts in WT
Figure 1. Dispensable role of NIK in steady-state hematopoiesis. (A): Clonogenic assays cultured in semisolid medium to study the mye-
loid progenitor compartment in basal conditions and after 7 days of cytokines exposure. (B): Stem cell compartment. Bone marrow (BM)
samples were analyzed by ﬂow cytometry. LSK (Lin2Sca11cKit1), SLAM (Lin2CD1501CD482), LT-HSC (LSKCD1352CD1501CD342), ST-
HSC (LSK CD1352CD341), and MPP (LSK CD1351) HSCs were studied (NIKaly/aly n5 6; WT n5 5). (C): Cell-cycle status of HSCs by analyz-
ing RNA and DNA content. Distribution of cells in the G0, G1, and S/G2/M phases of cell cycle in LSK and SLAM HSCs from NIKaly/aly
(n5 5) BM compared with control mice (n5 10). Abbreviations: CFU-GM, granulocyte-macrophage colony-forming unit; HSC, hematopoietic
stem cell; LSK, Lin2Sca11cKit1; NIK, NFjB inducing kinase.
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Figure 2. Impaired responses of hematopoietic stem cells NIKaly/aly to stressors. (A): Two-step transplantation assay. After total recon-
stitution of primary recipients with NIKaly/aly or WT cells, secondary transplant was performed with 7.53 106 cells of total BM from pri-
mary recipients mixed with 2.53 106 fresh competitor and kinetics of CD45.2 population was analyzed at 1, 2, and 5 mpt in PB of
transplanted mice (n5 5 per group). (B): Competitive repopulation assays. Engraftment kinetics of CD45.2 population in PB of lethally
irradiated mice transplanted with a mix of linage negative (Lin2) CD45.21 cells from BM of female NIKaly/aly or WT mice with competitor
(n5 10 per group, two independent experiments). **, p< .01. The results are normalized to the engraftment levels of WT cells (n5 5
per group) **, p< .01. (C): Engraftment levels in BM of primary recipients at 5 months post-transplant **, p< .01. (D): Absolute num-
bers of CD45.21 LSK (percentage of Sca11cKit1 cells within the Lin2 population) cells in BM of primary recipients at 5 months post-
transplant. *, p< .05. (E): Engraftment kinetics of CD45.2 population in PB of secondary recipients. Abbreviations: BM, bone marrow;
LSK, Lin2Sca11cKit1; NIK, NFjB inducing kinase.
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chimera at 4 dpt were slightly lower (but not signiﬁcant) com-
pared to those in NIKaly/aly chimera (Fig. 4A). The recovery of
the PB leukopenia was delayed in NIKaly/aly chimeric mice
compared to controls (at 15 and 30 dpt) (Fig. 4A), indicating
that NIK plays an essential role in HSC proliferation after a
stressor such as myelotoxic chemotherapy.
The absolute numbers of LSK cells in BM were no differ-
ent between NIKaly/aly and WT mice. Signiﬁcantly higher per-
centages of LSK NIKaly/aly were detected 6 days post-
treatment compared to those at day 2 (Fig. 4B). To further
study the response of HSC to 5-FU, we performed apoptosis
and cell cycle analysis of LSK at days 2 and 6. Proportions of
quiescent cells (G0) diminished over the 6 days period, and
were always signiﬁcantly higher in NIKaly/aly versus WT LSK.
On the contrary, percentages of cycling LSK were signiﬁcantly
lower among NIKaly/aly versus WT at days 2 (S phase) and 6
(G2/M). The analysis of apoptosis showed a signiﬁcant
decreased in the proportion of living cells at days 2 and 6
among NIKaly/aly LSK cells (Fig. 4D). These data suggested that
NIK deﬁciency compromised the HSC reconstitution ability
after myeloablative chemotherapy, due to a delayed cell cycle
progression and an elevated apoptosis rate. Together with the
competitive repopulation experiments, these results show
that HSCs need a fully active NIK protein to cope with stress-
ful conditions in vivo.
Aly/aly Progenitor Cells Have a Defective Expansion
Capacity Due to an Impaired Proliferation and
Increased Apoptosis During Stress
We also studied the effect of supraphysiological levels of cyto-
kines that drive hematopoietic cells into expansion in vitro.
We set up in vitro experiments to assess the proliferative
capacity of hematopoietic cells. Liquid cultures of Lin2 cells
from NIKaly/aly or WT mice were maintained during 14 days.
Total numbers of cells were determined weekly and we
observed a signiﬁcant impairment in the expansion capacity
of Lin2 cells from NIKaly/aly versus WT mice (Fig. 5A). These
results were conﬁrmed with a more homogeneous starting
HSC population. Ten thousand sorted LSK cells were placed in
liquid cultures and cells were counted weekly. After 14 days,
a signiﬁcant decrease in the fold expansion was observed in
NIKaly/aly HSC compared with WT HSC cells (Fig. 5B). These
data suggested that NIKaly/aly have a defective proliferative
capacity in the HSC compartment.
One possible explanation for this may be a defective pro-
liferation of NIKaly/aly hematopoietic cells compared to con-
trols. To test this hypothesis, Lin2 BM cells were labeled with
CFSE and dye dilution was analyzed as a means to evaluate
rounds of cell division. A marked delayed in the CFSE dilution
was observed in NIKaly/aly cells compared with WT ones. At
day 2, approximately more than 70% of WT cells had under-
gone three or more cell divisions, while only 18% NIKaly/aly
cells had reached three rounds of cell division (Fig. 5C). This
result indicated that the expansion defect in Lin2 cells from
NIKaly/aly mice was due in part to a defect in the proliferation
capacity. This result is consistent with the delayed recovery
observed after 5-FU treatment in vivo by accumulation on G0
phase and with the severe proliferative disadvantage
observed in competitive repopulating assays.
An increased rate of apoptosis of proliferating NIKaly/aly
hematopoietic cells could also account for the differences in the
ﬁnal total numbers. We analyzed cell viability to rule out that an
increased apoptotic ratio could explain the expansion defect
after exposure to cytokines. We found that NIKaly/aly and WT
hematopoietic cells differed in the proportions of apoptotic cells
in culture. Both at days 2 and 5 after culture initiation, NIKaly/aly
BM cells presented higher rates of apoptosis compared with WT
hematopoietic cells (Fig. 5C). The differences at day 2 were stat-
istically signiﬁcant. Similarly as 5-FU treated BM, these results
indicated that NIK plays an important role for maintaining viabil-
ity of hematopoietic cells after a proliferative stress.
The NIK-NFjB2 Pathway Controls HSCs During Stress
Hematopoiesis
Since NIK may signal through p100/p52 [18] and cRel [49], we
further investigated which of those pathways were involved in
the deﬁciencies found with the NIKaly/aly HSCs. For this, we
used NFjB22/2 [38] and cRel2/2 [39] mice and repeated the
experiments discussed above. The results obtained when using
NFjB22/2 HSCs were comparable to those described with
NIKaly/aly cells in similar experimental conditions. In competitive
repopulation assays, the levels of chimerism (donor CD45.2
cells) in PB of mice transplanted with cRel2/2 HSCs were not
inferior to those of mice transplanted with WT HSCs (Fig. 6A),
while mice transplanted with NFjB22/2 HSCs showed signiﬁ-
cantly lower levels than control (Fig. 6B). Furthermore, the lev-
els of NFjB22/2 engraftment decreased from 1 mpt to the
end of the experiment (25% at 1 mpt to 10% at 5 mpt) (Fig.
6B). The differentiation into B and T lymphoid and myeloid lin-
eages was normal in PB cRel2/2 engraftment but not in
NFjB22/2 (CD45.2) (Supporting Information Fig. S4). These
results suggest that defects in the NIK-p100/p52 pathway but
not in NIK-cRel pathway result in HSC dysfunction under prolif-
erative stress conditions. Proliferation defect of NFjB22/2
Figure 3. Homing ability of hematopoietic stem cells was not
affected by the NIKaly/aly mutation. Absolute numbers of
CD45.21 LSK (percentage of Sca11cKit1 cells within the Lin2
population) cells in BM of lethally irradiated P3B mice analyzed
16 hours after transplant (n5 5 per group). Abbreviations: BM,
bone marrow; LSK, Lin2Sca11cKit1; NIK, NFjB inducing kinase.
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hematopoietic stem/progenitor cells was also conﬁrmed by the
recovery of PB leukocyte counts after 5-FU treatment (Fig. 6C).
Finally, we further conﬁrmed a delayed cell-cycle progression in
response to cytokine stimulation in NFjB22/2 cells, by Lin2
CFSE labeling (Supporting Information Fig. S5A). We observed a
similar behavior between WT and cRel2/2 cells, a complete
delayed in NIKaly/aly cells, and a minor delay for NFjB22/2 cells
in the dilution of CFSE (Supporting Information Fig. S5A).
Figure 4. Delayed recovery of NIKaly/aly hematopoietic cells after 5-FU treatment. (A): WBC counts after 5-FU treatment in P3B mice
transplanted with total BM cells from NIKaly/aly or WT mice. The ﬁgure shows the percentage of WBC recovery normalized to pre-5FU
treatment values (n5 5 per group). *, p< .05. (B): Absolute number and percentage of LSK cells into BM of 5-FU treated mice. (C): Cell
cycle analysis. BM from NIKaly/aly or WT mice was analyzed after 2 days (n5 3 per group) and 6 days (n5 3 per group) of 5-FU treat-
ment. (D): Apoptosis analysis of LSK from treated mice, 2-day analysis (n5 3 per group) and 6-day analysis (n5 3 per group). Live cells
were DAPI2AnnexinV2, apoptotic/dead cells were DAPI2AnnexinV1and DAPI1AnnexinV1. *, p< .05. Abbreviations: 5-FU, 5-ﬂuorour-
acil; BM, bone marrow; LSK, Lin2Sca11cKit1; NIK, NFjB inducing kinase.
2832 Role of NIK in HSC Function Under Stress
VC AlphaMed Press 2015 STEM CELLS
As shown with NIKaly/aly mice, basal hematopoiesis was normal
in NFjB22/2 and cRel2/2 mice (Supporting Information
Fig. S6).
Gene Expression Profile Analysis
To explore the consequences of the defective NIKaly/aly pro-
tein in alternative NFKB signaling in HSCs in homeostatic
conditions, we investigated the gene expression proﬁle
of highly puriﬁed fresh LSK cells isolated from WT and
NIKaly/aly mice using whole mouse genome oligo microar-
rays. The rational was to know the transcriptional basal
state of HSC that could counterpart for its response to
stress.
Data analysis revealed that 301 genes were differen-
tially expressed (fold change 1.5 and p-value< .05) from
which 148 were upregulated (49.2%) and 153 (50.8%)
downregulated (Supporting Information Table S1). Based
on these results, there was no clear evidence for NIKaly/aly
Figure 5. Expansion impairment of NIKaly/aly bone marrow (BM)
cells in vitro due to proliferation defect and enhanced apoptosis.
(A): Liquid cultures of puriﬁed Lin2 BM population from NIKaly/aly
and WT mice, containing mSCF and hIL-11, were maintained dur-
ing 14 days and total cell numbers and viability were analyzed
weekly. *, p< .05. (B): Liquid cultures of freshly sorted LSK popu-
lation from NIKaly/aly and WT mice were maintained during 14
days and total cell numbers and viability were analyzed weekly.
**, p< .01. (C): Lin2 BM was labeled with CSFE and cultured in
presence of cytokines. CSFE dilution was analyzed several days
after culture started (above). An estimation of rounds of cell divi-
sion at day 2 is shown (down-left). Apoptotic cells (Annexin V1)
in in vitro culture of NIKaly/aly and WT Lin2 BM cells at days 2
and 5 after culture initiation (down-right). *, p< .05. Abbrevia-
tions: LSK, Lin2Sca11cKit1; NIK, NFjB inducing kinase.
Figure 6. Competitive repopulation assays to test NFjB22/2
and cRel2/2 hematopoietic stem cells functionality. We per-
formed competitive repopulation assays using mice knocked out
for components of either pathway downstream NIK. CD45.2
kinetics in PB of recipient mice was represented for cRel2/2 com-
petition (A) and NFjB22/2 competition (B) (n5 10 per group).
**, p< .01. (C): WBC counts recovery after 5-FU treatment of
NFjB22/2 chimera mice. Abbreviations: 5-FU, 5-ﬂuorouracil;
WBC, white blood cells.
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being neither an overall transcriptional inductor nor a
repressor.
We speciﬁcally focused on genes associated to cell cycle,
cell death, and cell proliferation, key processes in the assays
we have previously described. As shown in Table 1, genes
with a known positive role in cell proliferation were mainly
downregulated. However, genes promoting cell cycle arrest
were also downregulated in NIKaly/aly cells. In the same man-
ner, genes with either positive or negative roles in cell death
were similarly represented in number in the list of genes dif-
ferentially regulated by NIK.
Among these 301 genes, up to 12 have been previously
described as direct or indirect NFjB transcriptional targets
(http://www.bu.edu/nf-kb/gene-resources/target-genes/). Inter-
estingly, a search for putative binding sites on the regulatory
regions of the 153 downregulated transcripts revealed that 146
(95.4%) of them beared at least one target site for any of the
NFjB-transcription factor family members (Supporting Informa-
tion Table S3).
We then challenged these altered genes in an IPA pathway
analysis restricted to those pathways that had been previously
implicated in HSC. Supporting Information Figure S7 shows a
comprehensive list of statistically signiﬁcant altered pathways.
No classic pathways related to the HSC fate such as BMP/TGF-
b, Wnt, or HOX transcription factors family among others were
found. Pathways such as Retinoic Acid Receptor (RAR) activa-
tion (p-value .0012), production of nitric oxide, and reactive
oxygen species in macrophages (p-value .0012), involved in
Reactive Oxigen Species (ROS) regulation, appeared as the
most signiﬁcantly altered ones. Regarding NIK deﬁciency, path-
ways related to the function of NIK in the immune system
such as IL-12 signaling and production in macrophages (p-value
.0081), role of osteoblasts, osteoclasts, and chondrocytes in
rheumatoid arthritis (p-value .0234), and Lymphotoxin b recep-
tor signaling (p-value .038) were also signiﬁcantly altered.
DISCUSSION
In this study, we show that NIK has a role in the function of
hematopoietic stem/progenitor cells under stress, but seems
dispensable under homeostatic conditions. Of the various
downstream pathways that NIK may activate [18, 49, 50], the
NIK-p100/p52 pathway seems to be responsible for this func-
tion. NIK inactivation did not affect the numbers and propor-
tions of stem/progenitor cell populations in BM in steady-
state hematopoiesis, nor did it cause disturbances in mature
cell numbers in PB (except for the reported defects in B cells)
(Supporting Information Fig. S1). However, NIK-inactive HSCs
had an impaired response to stressors such as supraphysiolog-
ical levels of cytokines, myeloablative chemotherapy, or upon
hematopoietic transplantation (Figs. 2, 4, 5).
The NIKaly/aly mice used in this work bear a point muta-
tion in the Nik gene [51], which renders the kinase unable to
bind IKKa and P100 and so, p100 is not processed [52].
NIKaly/aly mice, as well as NIK2/2 mice [27], have been used
to study the role of NIK mainly in the immune system, since
these animals have defects on lymphoid organogenesis and
immune regulation [22, 23]. Some of these studies have
shown both an intrinsic defect and also an important role of
NIK in the stromal microenvironment of organs of the
immune system (thymus, spleen, and lymph nodes), which
negatively affected the function of NIKaly/aly immune cells.
Accordingly, marrow stromal cultures initiated with total BM
cells from NIKaly/aly mice have defects in supporting WT HSCs
(our unpublished data). In this study, the transfer of NIKaly/aly
HSCs into the WT microenvironment of recipients allowed us
to address the role of NIK in HSCs independently of its role
on the BM environment. NIKaly/aly HSCs engrafted in WT BM
did not improve their functional capacities, underscoring an
intrinsic role of NIK in HSCs, as shown in two different experi-
ments. NIKaly/aly HSCs placed on a WT BM did not respond as
efﬁciently as control HSCs to 5-FU (Fig. 4) nor did it engraft
as robustly in a competitive repopulation assay (Fig. 2A, 2E).
In fact, 5 months after the ﬁrst transplant, the numbers of
LSK BM cells were lower in the mice recipients of NIKaly/aly
HSCs compared to those of mice transplanted with WT HSCs
(Fig. 2D).
In vitro cultures showed that upon stimulation, NIKaly/aly
HSCs compartment, LSK, and the more heterogeneous Lin2
population required a longer time to undergo rounds of cell
divisions (Fig. 5B, left), plus they underwent apoptosis at
higher rates than WT HSCs (Fig. 5B, right). The differences in
apoptosis were more important early after the stimuli (Fig.
5B, right), in accordance with our previous results on acti-
vated T lymphocytes [21]. As a result of these combined
Table 1. Regulated genes affecting different biological process
Biological process NIK
aly/aly > WT NIKaly/aly < WT
Cell death Positive
regulation
TNFRSF11B (0.0151) APOE (0.0089)
TNFRSF11A PCBP4
PRKAA2 TXNIP
UBE2K (0.0202) LGALS1 (0.0274)
TRIM13 P2RX7
TNFSF12
UNC5A (0.0185)
STEAP3 (0.0106)
Negative
regulation
BEX2 (0.0121) MET (0.0219)
PARP16 (0.0095) IL4 (0.0206)
CHL1 (0.089) CX3CR1
GHR GAS1
MAPK8iP1(0.0099) HDAC1 (0.0008)
NKX3-2
Cell
proliferation
Positive
regulation
PPARGC1A (0.0456) MET (0.0219)
SMARCD3 GDF9 (0.0252)
LIPA (0.0436) IL4 (0.0206)
HDGFRP3 (0.070) CSF1R (0.0026)
MAPK1 (0.0408)
GAS1
HMGA2
HDAC1 (0.0189)
Negative
regulation
PKP2 (0.0234) APOE (0.0089)
IRF6 TXNIP
ROR2 (0.0027) CEBPA
Cell cycle Progression BEX2 (0.0121) PLCB1 (0.0308)
CENPF JUB (0.0051)
Arrest IRF6 PCBP4
TXNIP
E2F5
ZC3H12D (0.054)
GAS1
PARP3 (0.0360)
GAS2L3 (0.0460)
STEAP3 (0.0106)
MSH5 (0.0447)
Genes with no p-value resulted from analysis in which the fold-
change was the only criterion.
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defects (early apoptosis and permanent impairment of prolif-
eration), NIKaly/aly HSCs did not perform successfully in in vivo
competitive repopulation transplants, nor regenerated hema-
topoiesis after 5-FU as fast as control WT HSCs.
Under 5-FU induced stress, the cycling status of LSK cells
from NIKaly/aly was delayed compared to WT mice, as reﬂected
by a higher percentage of cells in G0 at days 2 and 6 after
treatment (Fig. 4C), and lower proportion of actively cycling
cells. The role of NIK in apoptosis after stress was shown by
the increased proportion of living cells after 5-FU treatment
in the WT versus NIKaly/aly (Fig. 4D), 1.2-fold increase at day 2
and 2.5-fold at day 6. In accordance with in vitro cultures
results, here we found that the day when LSK more actively
proliferated (day 6, cell cycle analysis) was the moment when
higher apoptosis was detected, likely due to higher sensitivity
to activation induced cell death in NIKaly/aly LSK HSC. The simi-
lar total numbers of LSK at days 2 and 6 post-5-FU likely
reﬂected a balance between the higher apoptosis of activated
cells and the higher proportions of quiescent LSK HSCs. An
additional consequence of the delayed cell cycle progression
of the NIKaly/aly LSK cell population was their kinetics in BM
after 5-FU. While day 2 values of LSK from NIKaly/aly were
comparable to those at steady-state (compare to Fig. 1B), a
faster increase from basal levels was detected in the LSK pro-
portions of WT mice. This increase was maintained at day 6
among LSK WT but proportions of NIKaly/aly LSK almost
doubled at day 6, probably reﬂecting the higher percentages
of quiescent LSK at day 2. It is well known that NFjB is
involved in survival/antiapoptosis through proteins such as
FLICE inhibitory protein, cIAP, surviving, Bcl-2, and Bcl-XL, and
regulates the expression of genes related to cell growth, pro-
liferation, differentiation, immune response, and inﬂammation
[53]. We and others previously showed that NIK-deﬁcient T
lymphocytes were not able to generate GVHD because of
high rates of apoptosis [21, 25]. Jin et al. described that
NIK2/2 mice (and NIK2/2 T cell-transferred Rag22/2 mice)
were resistant to EAE induction by Myelin Oligodendrocyte
Glycoproteine (MOG) immunization, mainly because their T
lymphocytes have limited proliferative capacity and Th17 dif-
ferentiation [26]. Our results suggest that the loss of NIK neg-
atively affects HSCs whenever they need to deal with stress.
The fact that we found the major disturbances in HSCs func-
tion after stress and not under physiological conditions may
suggest that the intensity of the signal should be important,
as stress signals for HSCs during steady-state hematopoiesis
should be milder than those during during hematopoietic
reconstitution, that is, BM transplantation or administration
of 5-FU. The absence of a fully functional NIK protein
resulted in a delay in the duration of the cell cycle (Fig. 4C,
5B, left) and in apoptosis (Fig. 4D, 5B, right) when coping
with stress. We cannot rule out the possibility that NIKaly/aly
HSCs may accumulate defects during steady state that only
manifest under protracted stresses.
We found comparable defects when using NIKaly/aly HSCs
and NFjb22/2 HSCs (Fig. 6B). These results underscore the
role of the NIK-p100/p52 activation pathway in HSCs. There
are two main pathways for NFjB activation. Canonical or clas-
sic pathway activation is rapid and transient and acts inde-
pendently of protein synthesis. Noncanonical or alternative
pathway is slower but persistent, and depends on de novo
protein synthesis [50, 54, 55]. Noncanonical pathway regulates
lymphoid organogenesis, B-cell survival and maturation, den-
dritic cell activation, and bone metabolism. Little is known
about the role of the alternative pathway in HSC function.
Zhao et al. [37] analyzed the HSC function in NFjb22/2/
Relb2/2 double Knockout (KO), in which the alternative NFjB
pathway is not functional. Similar to what we show here for
the NIKaly/aly and the NFjb22/2 mice, Zhao et al. described a
defect in the repopulation ability of double NFjb22/2/Relb2/
2 HSCs in competitive and noncompetitive assays. However,
these authors observed an increased frequency of LSK popula-
tion and a decreased of CD1501CD482LSK or
CD342CD1352LSK in steady state in the double KO mice.
They also observed a high proportion of proliferative cells in
LSK cells and decreased in apoptotic cells. Some of the HSC
defects described in the double KO model improved when
HSCs were transferred into a wild-type marrow environment.
In our models, NIKaly/aly mice did not present signiﬁcant dif-
ferences in HSC subpopulations nor in the cell cycle status in
basal conditions (Fig. 1), and the transfer into a WT BM did
not recover the functional capacities of HSCs (Figs. 2, 4). The
differences found between our experiments and those of
Zhao et al. may be related to the different KO molecules the
NIK protein should be active in the double KO model, suggest-
ing that in HSCs, NIK may also signal through mediators other
than p100-p52-Relb.
The number of NIK regulated genes in our gene expres-
sion analysis was low if we compare it with published data
(Supporting Information Fig. S7 and Supporting Information
Table S1). One possible explanation is that NIK and genes of
the alternative NFjB pathway are expressed at higher levels
in lymphoid tissues compared to LSK HSCs. However, some
of the genes identiﬁed in our study have already been found
in other cellular systems, validating the signiﬁcance of our
work (Supporting Information Table S2) [56–59]. The results
from the array study supported the ﬁndings obtained in the
functional assays shown in this work. The downregulation in
the expression levels of genes that have a positive role in
cell proliferation combined with the downregulation in the
expression levels of genes involved in cell cycle arrest (Table
1) in resting NIKaly/aly HSCs suggest that these stem cells are
not impaired for activating the cell cycle machinery but they
are not fully equipped to actively respond to proliferative
signals. In accordance with this, we did not ﬁnd any signiﬁ-
cant difference in the distribution of HSCs along the different
phases of the cell cycle in steady-state (Fig. 1C) but did ﬁnd
a delay on CFSE dilution in in vitro experiments. Regarding
the different levels of apoptosis found in Figure 5B, basal
expression levels of apoptosis-related genes were not
affected by the NIKaly/aly mutation. This suggests that apo-
ptosis is related to activation of HSC in these cells, as we
have previously shown during T-cell activation [21]. The
results of our analysis revealed a potential role for pathways
(in Supporting Information Fig. S7) already related with HSC
survival, that is, ROS metabolism [9].
Cells from the immune system and from nonhemato-
poietic tissues produce cytokines during infections or stress
that activate HSC through innate immune signaling pathways.
Conversely, HSC can respond to Toll-Like receptors (TLR) stim-
ulation [60, 61] leading to an increased myeloid cell produc-
tion and NFjB has been implicated in this response. It is
temptative to speculate that a deﬁcit in NFjB signaling in this
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context (as shown in our models) would result in an impaired
response to the stress. It is interesting to note that molecules
related with TLR signaling came up in our gene expression
analysis, such as Tlr6, Irf8, Il4, some TNF receptors (Tnfrsf11b),
or TGF-b signaling (Smad5), all of them genes that regulate
proliferation and differentiation of HSC.
CONCLUSIONS
In summary, our results suggest that NIK and the noncanon-
ical NFjB pathway are needed for HSCs to respond to
stressful conditions, while it could be dispensable during
steady-state hematopoiesis. The inactivation of this kinase
would be detrimental for the hematopoietic system in vivo,
a strategy we initially contemplated in the allogeneic set-
ting [21].
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